Interventional Cardiology, Department of Cardio-Thoracic and Vascular Sciences, Ospedale dell'Angelo, Via Paccagnella, 12, 35128 Mestre, Venice, Italy.
J Invasive Cardiol. 2022 Sep;34(9):E689. doi: 10.25270/jic/22.00047.
A 91-year-old man presented with syncope secondary to severe aortic stenosis. A transthoracic echocardiogram revealed a calcified stenotic trileaflet aortic valve (AV) with a mean gradient of 60 mm Hg and cardiac computed tomography demonstrated a heavily calcified trileaflet AV without commissural fusion. Following heart team discussion, transfemoral transcatheter AV replacement (TAVR) was the preferred option in view of the patient's age. Due to the severe aortic leaflet calcifications, a balloon-expandable 32-mm Myval transcatheter heart valve (Meril Life Sciences) implantation preceded by balloon predilation was planned. After numerous catheter and wire exchanges, the transcatheter heart valve was finally implanted with a good final result.
一位 91 岁男性因严重主动脉瓣狭窄导致晕厥。经胸超声心动图显示三叶瓣主动脉瓣钙化伴狭窄,平均跨瓣压差为 60mmHg,心脏计算机断层扫描显示三叶瓣主动脉瓣严重钙化且无交界融合。经心脏专家组讨论,鉴于患者年龄较大,经股动脉经导管主动脉瓣置换术(TAVR)是首选方案。由于主动脉瓣叶严重钙化,计划先行球囊预扩张,随后植入 32mm 球囊扩张式 Myval 经导管心脏瓣膜(Meril Life Sciences)。经过多次导管和导丝交换,最终成功植入经导管心脏瓣膜,效果良好。